Neurotech's ENCELTO has emerged as a groundbreaking solution for MacTel, offering new therapeutic possibilities for those affected by this rare eye condition. In a development that medical experts are calling transformative, the FDA has granted approval to Neurotech's ENCELTO for the treatment of Macular Telangiectasia Type 2 (MacTel). This milestone marks the first and only...